FORWARD FEATURES CALENDAR

Deals

Shore Capital closes $450m F&B fund

Shore Capital Partners, the Chicago-based private equity firm founded by billionaire Justin Ishbia, has closed its third dedicated food and beverage fund at $450m, targeting investments in companies generating $5m to $100m in annual revenue, according to a report by Bloomberg.

AustralianSuper to expand PE portfolio

AustralianSuper, Australia’s largest pension fund, is accelerating its private equity exposure with plans to onboard four new private equity managers by year-end, according to a report by Bloomberg citing Chief Investment Officer Mark Delaney.

Vista sells remaining Cvent stake to Blackstone in $1.3bn deal

Vista Equity Partners has fully exited its investment in event software company Cvent, selling its remaining minority stake to Blackstone in a $1.3bn deal. The transaction finalises Blackstone’s ownership of Cvent following its $4.6bn take-private acquisition in 2023.

KKR acquires Australian poultry operator ProTen

Global investment firm KKR is to acquire ProTen, one of Australia’s largest broiler chicken growers, from Aware Super, according to a joint statement released on Wednesday. Financial terms of the transaction have not been disclosed.

KKR tops Advent with £4.7bn Spectris offer

US private equity giant KKR has agreed to acquire UK-listed scientific instruments maker Spectris in a deal worth approximately £4.7bn ($6.5bn), including debt, after outbidding rival suitor Advent International, according to a report by Reuters.

Brightstar acquires PlayAGS for $1.1bn

Brightstar Capital Partners, a private equity firm focused on investing in business services, industrials, consumer, and government services and technology companies, has acquired PlayAGS, a global full-service gaming supplier of high-performing slot, table, and interactive products.

Torrent to acquire KKR-backed JB Pharma for $1.4bn

Torrent Pharmaceuticals has entered into a definitive agreement to acquire private equity firm KKR’s controlling stake in JB Chemicals & Pharmaceuticals in a transaction valued at approximately $1.4bn, marking one of the largest healthcare M&A deals in India this year, according to a report by Bloomberg.

Events

12 November, 2026 – 5:00 pm

Directory Listings